Celularity Inc. CELU
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 18.67M | 18.97M | 26.55M | 40.58M | 44.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.67M | 18.97M | 26.55M | 40.58M | 44.59M |
| Cost of Revenue | 15.08M | 17.97M | 20.07M | 20.04M | 20.02M |
| Gross Profit | 3.59M | 998.00K | 6.48M | 20.54M | 24.57M |
| SG&A Expenses | 38.48M | 46.17M | 51.27M | 52.26M | 55.60M |
| Depreciation & Amortization | -436.00K | -418.00K | -418.00K | 1.44M | 1.49M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.08M | 78.01M | 85.95M | 89.25M | 91.94M |
| Operating Income | -47.42M | -59.04M | -59.40M | -48.67M | -47.35M |
| Income Before Tax | -45.86M | -71.09M | -91.71M | -80.65M | -73.67M |
| Income Tax Expenses | 3.00K | 3.00K | 3.00K | -- | -- |
| Earnings from Continuing Operations | -45.86 | -71.09 | -91.72 | -80.65 | -73.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.86M | -71.09M | -91.72M | -80.65M | -73.67M |
| EBIT | -47.42M | -59.04M | -59.40M | -48.67M | -47.35M |
| EBITDA | -41.16M | -52.49M | -52.61M | -41.36M | -39.91M |
| EPS Basic | -1.69 | -2.73 | -3.60 | -3.34 | -3.19 |
| Normalized Basic EPS | -0.92 | -1.55 | -1.94 | -1.90 | -1.80 |
| EPS Diluted | -1.70 | -2.74 | -3.60 | -3.34 | -3.19 |
| Normalized Diluted EPS | -0.92 | -1.55 | -1.94 | -1.90 | -1.80 |
| Average Basic Shares Outstanding | 113.22M | 107.89M | 102.35M | 96.19M | 91.82M |
| Average Diluted Shares Outstanding | 114.45M | 109.12M | 102.35M | 96.19M | 91.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |